Newsletter | March 29, 2024

03.29.24 -- Outsourcing Nirvana At Eli Lilly


Outsourcing Nirvana At Eli Lilly

Mark Butchko has been at Eli Lilly for 24 years, currently serving as Associate Vice President - Global Quality Laboratories. He draws from that longevity to describe what he’s currently experiencing, and what the future of outsourcing might look like from his vantage point.

Super Generics: Market Trends In Europe

Super generics combine advanced formulations and delivery methods, and improved bioavailability, compared to traditional generics. This article shares the market research trends of the European market.


Early Development Considerations For NCE Success: Quality Systems

Leveraging robust quality systems can improve efficiency throughout the product development life cycle and help companies avoid unnecessary knowledge and tech transfer, saving both time and cost.

Process Re-Design For Sustainability In Small Molecule Manufacturing

Review the optimization of the manufacturing process of a pharmaceutical intermediate and discover how yield can be improved substantially via suitable reaction engineering.


Oral Solid Dose Formulation And Lab Scale Capabilities

We provide a formulation design based on a strong scientific understanding and decoding interplay of materials and process parameters to ensure product integrity.

Lab Equipment And Testing Site Matrix

Our analytical and testing services are offered as both standalone services as well as complementing our expertise in drug substance and drug product development and manufacturing depending on your specific program needs.


Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: